InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Gorovitz Aaron, 董事. Officer active across 1 company, notably NRX Pharmaceuticals, Inc.. Aggregated, 2 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €10k. History available since 30 August 2023. The latest transaction was disclosed on 30 August 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Aaron Gorovitz is a Director at NRX Pharmaceuticals, Inc. As a board member, he participates in the governance of the company and strategic decision-making. His experience in the pharmaceutical sector allows him to make significant contributions to discussions on the company's direction. He is committed to supporting growth and innovation within NRX Pharmaceuticals.